Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

ClinicalTrials.gov ID: NCT01011049

Public ClinicalTrials.gov record NCT01011049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity of Revaccination With Influenza Vaccine in Healthy Adult Subjects Aged 18 to 64 Years Who Were Previously Vaccinated With Fluzone ID or Fluzone IM

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to generate additional data on the immunogenicity and safety of revaccination with Fluzone Intradermal (ID) or Fluzone Intramuscular (IM) vaccine. Primary Objective: * To evaluate and describe the safety profile of revaccination with Fluzone ID for all participants. Secondary Objective: * To describe immunogenicity following revaccination with Fluzone ID or Fluzone IM.

Study identification

NCT ID
NCT01011049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
1,250 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
May 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Apr 14, 2016

2009 – 2010

United States locations

U.S. sites
44
U.S. states
23
U.S. cities
41
Facility City State ZIP Site status
Not listed Hoover Alabama 35216 —
Not listed Huntsville Alabama 35802 —
Not listed Mobile Alabama 36608 —
Not listed Chandler Arizona 85224 —
Not listed Mesa Arizona 85213 —
Not listed Tempe Arizona 85282 —
Not listed Tucson Arizona 85711 —
Not listed Fountain Valley California 92708 —
Not listed San Diego California 92103 —
Not listed Milford Connecticut 06460 —
Not listed Melbourne Florida 32935 —
Not listed Pembroke Pines Florida 33024 —
Not listed Pinellas Park Florida 33781 —
Not listed Boise Idaho 83642 —
Not listed Chicago Illinois 60610 —
Not listed Iowa City Iowa 52242 —
Not listed Wichita Kansas 67207 —
Not listed Lexington Kentucky 40509 —
Not listed Madisonville Kentucky 42431 —
Not listed Rockville Maryland 20850 —
Not listed Kansas City Missouri 64114 —
Not listed Springfield Missouri 65802 —
Not listed St Louis Missouri 63104 —
Not listed Albuquerque New Mexico 87108 —
Not listed Binghamton New York 13901 —
Not listed Endwell New York 13760 —
Not listed Rochester New York 14609 —
Not listed Rochester New York 14621 —
Not listed Cary North Carolina 27518 —
Not listed Raleigh North Carolina 27609 —
Not listed Cincinnati Ohio 45249 —
Not listed Allentown Pennsylvania 18102 —
Not listed Bensalem Pennsylvania 19020 —
Not listed Warwick Rhode Island 02886 —
Not listed Mt. Pleasant South Carolina 29464 —
Not listed Nashville Tennessee 37203 —
Not listed Austin Texas 78705 —
Not listed Fort Worth Texas 76107 —
Not listed Fort Worth Texas 76135 —
Not listed San Angelo Texas 76904 —
Not listed Salt Lake City Utah 84109 —
Not listed Salt Lake City Utah 84121 —
Not listed West Jordan Utah 84088 —
Not listed Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01011049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01011049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →